Large-vessel vasculitis is a group of vasculitides that includes giant cell arteritis (GCA) and Takayasu’s arteritis (TAK), disorders that often present a diagnostic and therapeutic challenge to healthcare providers in […]
The COllaborative INitiatives (COIN) department of the American College of Rheumatology (ACR) is currently working with ACR/ARHP members and external collaborators to develop educational materials for healthcare providers to increase […]
No one is more qualified than you to tell lawmakers how their policies affect your ability to provide quality care and your patients’ ability to access it. Think contacting your […]
In 2017, we saw the defeat of efforts to repeal the Affordable Care Act, the cancellation of the Medicare Part B Drug Reimbursement Project proposed by CMS, extended flexibilities in […]
The Rheumatology Research Foundation is offering the latest in the Rodnan Commemorative Gout Print series for sale in the ACR Discovery Center in the Exhibit Hall. As both a vintage […]
Over the past few years, there have been breakthroughs in biologic therapies in the treatment of rheumatologic conditions. This has opened the door for new types of biological products such […]
In addition to the support provided for the 2017 ACR/ARHP Annual Meeting, the ACR, the ARHP, and the Foundation wish to thank the following organizations for providing support for activities […]
This year’s TechMed sub-track includes two sessions that will focus on how clinicians and researchers can use digital and social media to directly engage with their colleagues, their patients, and […]
Join the ACR for a weekend of high-impact education at the 2018 State-of-the-Art Clinical Symposium, held April 13 – 15, 2018, in Chicago. The program offers information on cutting-edge clinical […]
Changes to reimbursement introduced by the Medicare Access and CHIP Reauthorization Act (MACRA) will affect your Medicare income for 2019. “Rheumatologists generally know that MACRA is up and running,” said […]